Hu Yu-hua, Yu Li-jie, Shao En-de, Wu Jian-liang, Ji Jian-wen
Department of Neurosurgery, Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, China.
Chin Med J (Engl). 2009 Jan 20;122(2):205-11.
Our previous studies demonstrated that mutant IkappaBalpha (IkappaBalphaM) inhibited the occurrence, growth and angiogenesis of human glioblastoma multiform (GBM). However, the specific mechanism by which IkappaBalphaM regulates protein-degrading enzymes secreted from GBM to inhibit invasion and metastasis has remained unclear. The aim of the present study was to investigate the regulatory role and significance of IkappaBalphaM genes in the expression of tissue inhibitor of metalloproteinase (TIMP)-2 and matrix metalloproteinase (MMP)-9 in human GBM.
We established the following four GBM cell lines stably expressing IkappaBalphaM by plasmid construction, gene transfection and screening for IkappaBalphaM protein expression: mutant IkappaBalpha-transfected cells (G36Delta-M), wild-type IkappaBalpha-transfected cells (G36Delta-W), empty plasmid transfected cells (G36Delta-P) and untransfected cells (G36Delta). The TIMP-2 and MMP-9 expression was detected by RT-PCR and Western blotting. Tumor cells were then implanted subcutaneously into nude mice to establish an animal model of ectopic tumor growth, and TIMP-2 and MMP-9 expression was determined by immunohistochemical methods.
The results showed that there was a significant increase in TIMP-2 expression and a significant decrease in MMP-9 expression in the G36Delta-M group at both the RNA and protein levels compared with the G36Delta-W group, G36Delta-P group and G36Delta group. Similar results were observed in the immunohistochemical staining analysis of tumor tissues. In the G36Delta-M group, TIMP-2 expression was significantly higher while MMP-9 expression was significantly lower than in the other three groups.
Our findings indicate that IkappaBalphaM inhibits the activation of NF-kappaB. It significantly up-regulates TIMP-2 expression in human malignant glioma cells and down-regulates the expression of MMP-9. Thus, IkappaBalphaM maintains the integrity of the extracellular matrix and further inhibits the growth and metastasis of tumor tissues.
我们之前的研究表明,突变型IκBα(IκBαM)可抑制人多形性胶质母细胞瘤(GBM)的发生、生长和血管生成。然而,IκBαM调节GBM分泌的蛋白降解酶以抑制侵袭和转移的具体机制仍不清楚。本研究的目的是探讨IκBαM基因在人GBM中金属蛋白酶组织抑制剂(TIMP)-2和基质金属蛋白酶(MMP)-9表达中的调节作用及意义。
我们通过质粒构建、基因转染并筛选IκBαM蛋白表达,建立了以下四种稳定表达IκBαM的GBM细胞系:突变型IκBα转染细胞(G36Δ-M)、野生型IκBα转染细胞(G36Δ-W)、空质粒转染细胞(G36Δ-P)和未转染细胞(G36Δ)。通过RT-PCR和蛋白质印迹法检测TIMP-2和MMP-9的表达。然后将肿瘤细胞皮下植入裸鼠体内,建立异位肿瘤生长动物模型,并用免疫组织化学方法测定TIMP-2和MMP-9的表达。
结果显示,与G36Δ-W组、G36Δ-P组和G36Δ组相比,G36Δ-M组在RNA和蛋白质水平上TIMP-2表达均显著增加,MMP-9表达均显著降低。在肿瘤组织的免疫组织化学染色分析中也观察到类似结果。在G36Δ-M组中,TIMP-2表达显著高于其他三组,而MMP-9表达显著低于其他三组。
我们的研究结果表明,IκBαM可抑制NF-κB的激活。它显著上调人恶性胶质瘤细胞中TIMP-2的表达,并下调MMP-9的表达。因此,IκBαM维持细胞外基质的完整性,并进一步抑制肿瘤组织的生长和转移。